Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis
Launched by ZHONGSHAN HOSPITAL XIAMEN UNIVERSITY · May 22, 2024
Trial Information
Current as of February 14, 2025
Completed
Keywords
ClinConnect Summary
The study analyzes the clinical characteristics, including symptoms and physical examinations, as well as the types of fungal infections. It compares the efficacy of patient self-application versus physician application of triamcinolone acetonide econazole cream in treating otomycosis two weeks after starting treatment. Furthermore, the study also compares the recurrence rates six months after treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1.The chief complaint was ear discomfort, including tinnitus, a feeling of blockage or fullness, pruritis, otalgia, otorrhea and decreased hearing; 2. Physical examination findings:presence of fungal hyphae or accumulations that appear creamy or cheese-like or resembling abnormal earwax (crusts, films) , skin redness, erosion, swelling, or granulation tissue within the ear canal; 3. Positive results in fungal culture.
- Exclusion Criteria:
- • The exclusion criteria included otitis media, tympanic membrane perforation, and conditions post-radiotherapy.
Trial Officials
Chunsheng Chunsheng
Principal Investigator
Xiamen University Zhongshan Hospital
About Zhongshan Hospital Xiamen University
Zhongshan Hospital, affiliated with Xiamen University, is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and exemplary patient care. As a prominent sponsor of clinical trials, the hospital leverages its robust research capabilities and interdisciplinary collaboration to explore novel therapeutic interventions and enhance treatment protocols across various medical fields. Committed to upholding the highest ethical standards, Zhongshan Hospital fosters an environment conducive to scientific inquiry, aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xiamen, Fujian, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0